Other Affiliated Sites
开元体育(中国)官方网站
开元体育·(中国)官方APP下载
开元体育平台(中国)官方网站app下载
开元体育官网(中国)官方下载-IOS/安卓通用版/手机APP下载
开云app(中国)官方网站-ios/安卓版/手机版app下载
开云·APP官方入口(中国)官方网站-IOS/安卓通用版/手机app
开云·APP(kaiyun)(中国)官方网站-IOS/Android通用版/手机app下载
华体会·(HTH)官网APP下载 - Apple app store
江南体育·(中国)官方网站 - ios/安卓版/手机APP下载
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Preparations Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
2022.01.27
VOLUNTARY ANNOUNCEMENT LAUNCH OF HEPARIN SODIUM INJECTION IN THE USA
2022.01.27
VOLUNTARY ANNOUNCEMENT LAUNCH OF HEPARIN SODIUM INJECTION IN THE USA
2022.01.05
2022年第一次临时股东大会的法律意见书
2022.01.05
2022年第一次临时股东大会决议公告
2022.01.05
关于全资子公司为上市公司提供反担保的公告
2022.01.04
Overseas Regulatory Announcement
2022.01.04
POLL RESULTS OF THE 2022 FIRST EXTRAORDINARY GENERAL MEETING HELD ON 4 JANUARY 2...
2021.12.13
Notification Letter and Request Form to Non-Registered Shareholders
2021.12.13
NOTICE OF THE 2022 FIRST EXTRAORDINARY GENERAL MEETING
2021.12.13
PROXY FORM FOR THE 2022 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON TUESDA...
第一页
上一页
7
8
9
10
11
下一页
最后一页
